Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Fused in sarcoma silences HIV gene transcription and maintains viral latency through suppressing AFF4 gene activation.

Krasnopolsky S, Marom L, Victor RA, Kuzmina A, Schwartz JC, Fujinaga K, Taube R.

Retrovirology. 2019 Jun 25;16(1):16. doi: 10.1186/s12977-019-0478-x.

2.

A hyperthermophilic protein G variant engineered via directed evolution prevents the formation of toxic SOD1 oligomers.

Dagan B, Oren O, Banerjee V, Taube R, Papo N.

Proteins. 2019 Sep;87(9):738-747. doi: 10.1002/prot.25700. Epub 2019 May 11.

PMID:
31017342
3.

An Engineered Variant of the B1 Domain of Protein G Suppresses the Aggregation and Toxicity of Intra- and Extracellular Aβ42.

Banerjee V, Oren O, Dagan B, Taube R, Engel S, Papo N.

ACS Chem Neurosci. 2019 Mar 20;10(3):1488-1496. doi: 10.1021/acschemneuro.8b00491. Epub 2018 Nov 28.

PMID:
30428260
4.

An Aβ42 variant that inhibits intra- and extracellular amyloid aggregation and enhances cell viability.

Oren O, Banerjee V, Taube R, Papo N.

Biochem J. 2018 Oct 9;475(19):3087-3103. doi: 10.1042/BCJ20180247.

PMID:
30213841
5.

Measles Virus Persistent Infection of Human Induced Pluripotent Stem Cells.

Naaman H, Rabinski T, Yizhak A, Mizrahi S, Avni YS, Taube R, Rager B, Weinstein Y, Rall G, Gopas J, Ofir R.

Cell Reprogram. 2018 Feb;20(1):17-26. doi: 10.1089/cell.2017.0034.

6.

Organic matter quality structures benthic fatty acid patterns and the abundance of fungi and bacteria in temperate lakes.

Taube R, Ganzert L, Grossart HP, Gleixner G, Premke K.

Sci Total Environ. 2018 Jan 1;610-611:469-481. doi: 10.1016/j.scitotenv.2017.07.256. Epub 2017 Sep 14.

PMID:
28818662
7.

A computational combinatorial approach identifies a protein inhibitor of superoxide dismutase 1 misfolding, aggregation, and cytotoxicity.

Banerjee V, Oren O, Ben-Zeev E, Taube R, Engel S, Papo N.

J Biol Chem. 2017 Sep 22;292(38):15777-15788. doi: 10.1074/jbc.M117.789610. Epub 2017 Aug 2.

8.

Super elongation complex promotes early HIV transcription and its function is modulated by P-TEFb.

Kuzmina A, Krasnopolsky S, Taube R.

Transcription. 2017 May 27;8(3):133-149. doi: 10.1080/21541264.2017.1295831. Epub 2017 Feb 17.

9.

Functional Mimetics of the HIV-1 CCR5 Co-Receptor Displayed on the Surface of Magnetic Liposomes.

Kuzmina A, Vaknin K, Gdalevsky G, Vyazmensky M, Marks RS, Taube R, Engel S.

PLoS One. 2015 Dec 2;10(12):e0144043. doi: 10.1371/journal.pone.0144043. eCollection 2015. Erratum in: PLoS One. 2015;10(12):e0146309.

10.

Bacteria-based analysis of HIV-1 Vpu channel activity.

Taube R, Alhadeff R, Assa D, Krugliak M, Arkin IT.

PLoS One. 2014 Oct 1;9(10):e105387. doi: 10.1371/journal.pone.0105387. eCollection 2014.

11.

A single point mutation in cyclin T1 eliminates binding to Hexim1, Cdk9 and RNA but not to AFF4 and enforces repression of HIV transcription.

Kuzmina A, Verstraete N, Galker S, Maatook M, Bensaude O, Taube R.

Retrovirology. 2014 Jul 1;11:51. doi: 10.1186/1742-4690-11-51.

12.

A Cyclin T1 point mutation that abolishes positive transcription elongation factor (P-TEFb) binding to Hexim1 and HIV tat.

Verstraete N, Kuzmina A, Diribarne G, Nguyen VT, Kobbi L, Ludanyi M, Taube R, Bensaude O.

Retrovirology. 2014 Jul 1;11:50. doi: 10.1186/1742-4690-11-50.

13.

Health care utilization patterns of homeless individuals in Boston: preparing for Medicaid expansion under the Affordable Care Act.

Bharel M, Lin WC, Zhang J, O'Connell E, Taube R, Clark RE.

Am J Public Health. 2013 Dec;103 Suppl 2:S311-7. doi: 10.2105/AJPH.2013.301421. Epub 2013 Oct 22.

14.

Preferential lentiviral targeting of astrocytes in the central nervous system.

Fassler M, Weissberg I, Levy N, Diaz-Griffero F, Monsonego A, Friedman A, Taube R.

PLoS One. 2013 Oct 2;8(10):e76092. doi: 10.1371/journal.pone.0076092. eCollection 2013.

15.

The efficacy of an immunoisolating membrane system for islet xenotransplantation in minipigs.

Neufeld T, Ludwig B, Barkai U, Weir GC, Colton CK, Evron Y, Balyura M, Yavriyants K, Zimermann B, Azarov D, Maimon S, Shabtay N, Rozenshtein T, Lorber D, Steffen A, Willenz U, Bloch K, Vardi P, Taube R, de Vos P, Lewis EC, Bornstein SR, Rotem A.

PLoS One. 2013 Aug 1;8(8):e70150. doi: 10.1371/journal.pone.0070150. Print 2013.

16.

Microbial diversity and biochemical potential encoded by thermal spring metagenomes derived from the Kamchatka Peninsula.

Wemheuer B, Taube R, Akyol P, Wemheuer F, Daniel R.

Archaea. 2013;2013:136714. doi: 10.1155/2013/136714. Epub 2013 Feb 27.

17.

Lost in transcription: molecular mechanisms that control HIV latency.

Taube R, Peterlin M.

Viruses. 2013 Mar 21;5(3):902-27. doi: 10.3390/v5030902. Review.

18.

ZNF750 is expressed in differentiated keratinocytes and regulates epidermal late differentiation genes.

Cohen I, Birnbaum RY, Leibson K, Taube R, Sivan S, Birk OS.

PLoS One. 2012;7(8):e42628. doi: 10.1371/journal.pone.0042628. Epub 2012 Aug 24.

19.

In vivo selection of CD4(+) T cells transduced with a gamma-retroviral vector expressing a single-chain intrabody targeting HIV-1 tat.

Braun SE, Taube R, Zhu Q, Wong FE, Murakami A, Kamau E, Dwyer M, Qiu G, Daigle J, Carville A, Johnson RP, Marasco WA.

Hum Gene Ther. 2012 Sep;23(9):917-31. doi: 10.1089/hum.2011.184.

20.

Modulation of hepatitis C virus release by the interferon-induced protein BST-2/tetherin.

Dafa-Berger A, Kuzmina A, Fassler M, Yitzhak-Asraf H, Shemer-Avni Y, Taube R.

Virology. 2012 Jul 5;428(2):98-111. doi: 10.1016/j.virol.2012.03.011. Epub 2012 Apr 20.

21.

Functional characterization of a human cyclin T1 mutant reveals a different binding surface for Tat and HEXIM1.

Kuzmina A, Hadad U, Fujinaga K, Taube R.

Virology. 2012 May 10;426(2):152-61. doi: 10.1016/j.virol.2012.01.033. Epub 2012 Feb 18.

22.

The Boston Health Care for the Homeless Program: a public health framework.

O'Connell JJ, Oppenheimer SC, Judge CM, Taube RL, Blanchfield BB, Swain SE, Koh HK.

Am J Public Health. 2010 Aug;100(8):1400-8. doi: 10.2105/AJPH.2009.173609. Epub 2010 Jun 17.

23.

Lentivirus display: stable expression of human antibodies on the surface of human cells and virus particles.

Taube R, Zhu Q, Xu C, Diaz-Griffero F, Sui J, Kamau E, Dwyer M, Aird D, Marasco WA.

PLoS One. 2008 Sep 11;3(9):e3181. doi: 10.1371/journal.pone.0003181.

24.

Efficient production of HIV-1 viral-like particles in mouse cells.

Diaz-Griffero F, Taube R, Muehlbauer SM, Brojatsch J.

Biochem Biophys Res Commun. 2008 Apr 11;368(3):463-9. doi: 10.1016/j.bbrc.2007.12.195. Epub 2008 Jan 30.

PMID:
18241668
25.

Neuropathy progression in Charcot-Marie-Tooth disease type 1A.

Shy ME, Chen L, Swan ER, Taube R, Krajewski KM, Herrmann D, Lewis RA, McDermott MP.

Neurology. 2008 Jan 29;70(5):378-83. doi: 10.1212/01.wnl.0000297553.36441.ce.

PMID:
18227419
26.

Evolutionary chemistry approach toward finding novel inhibitors of the type 2 diabetes target glucose-6-phosphate translocase.

Bräuer S, Almstetter M, Antuch W, Behnke D, Taube R, Furer P, Hess S.

J Comb Chem. 2005 Mar-Apr;7(2):218-26.

PMID:
15762749
27.
28.

A minimal chimera of human cyclin T1 and tat binds TAR and activates human immunodeficiency virus transcription in murine cells.

Fujinaga K, Irwin D, Taube R, Zhang F, Geyer M, Peterlin BM.

J Virol. 2002 Dec;76(24):12934-9.

29.

P-TEFb containing cyclin K and Cdk9 can activate transcription via RNA.

Lin X, Taube R, Fujinaga K, Peterlin BM.

J Biol Chem. 2002 May 10;277(19):16873-8. Epub 2002 Mar 7.

32.

Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome.

Sawaya BE, Khalili K, Gordon J, Taube R, Amini S.

J Biol Chem. 2000 Nov 10;275(45):35209-14.

33.

Flavopiridol inhibits P-TEFb and blocks HIV-1 replication.

Chao SH, Fujinaga K, Marion JE, Taube R, Sausville EA, Senderowicz AM, Peterlin BM, Price DH.

J Biol Chem. 2000 Sep 15;275(37):28345-8.

34.
35.

Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1.

Taube R, Fujinaga K, Irwin D, Wimmer J, Geyer M, Peterlin BM.

J Virol. 2000 Jan;74(2):892-8.

36.

Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation.

Taube R, Fujinaga K, Wimmer J, Barboric M, Peterlin BM.

Virology. 1999 Nov 25;264(2):245-53. Review. No abstract available.

37.

Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b.

Wimmer J, Fujinaga K, Taube R, Cujec TP, Zhu Y, Peng J, Price DH, Peterlin BM.

Virology. 1999 Mar 1;255(1):182-9.

38.
39.
40.

Reverse transcriptase of mouse mammary tumour virus: expression in bacteria, purification and biochemical characterization

Taube R, Loya S, Avidan O, Perach M, Hizi A.

Biochem J. 1998 Jun 15;332 (Pt 3):807-8. No abstract available.

41.

Reverse transcriptase of mouse mammary tumour virus: expression in bacteria, purification and biochemical characterization.

Taube R, Loya S, Avidan O, Perach M, Hizi A.

Biochem J. 1998 Feb 1;329 ( Pt 3):579-87. Erratum in: Biochem J 1998 Jun 15;332(Pt 3):808.

44.

Strand breaks after the decay of iodine-125 in proximity to plasmid pBR322 DNA.

Sahu SK, Kortylewicz ZP, Baranowska-Kortylewicz J, Taube RA, Adelstein SJ, Kassis AI.

Radiat Res. 1997 Apr;147(4):401-8.

PMID:
9092918
45.

Pearls.

Hewson C, Askinasi JK, Goyle V, Casa DJ, Hamilton DR, Taube R.

Phys Sportsmed. 1994 Jun;22(6):8. doi: 10.1080/00913847.1994.11947645. No abstract available.

PMID:
29260973
46.

Pearls.

David CP, Taube R, Glazer RM, Askinasi JK.

Phys Sportsmed. 1994 May;22(5):40-42. doi: 10.1080/00913847.1994.11947637. No abstract available.

PMID:
29272629
47.

Managing Tibial Stress Fractures.

Taube RR, Wadsworth LT, Johnson RJ.

Phys Sportsmed. 1993 Apr;21(4):123-30. doi: 10.1080/00913847.1993.11710368.

PMID:
27447774
48.

Peliosis of the spleen: a rare cause of spontaneous splenic rupture with surgical implications.

Kohr RM, Haendiges M, Taube RR.

Am Surg. 1993 Mar;59(3):197-9. Review.

PMID:
8476160
49.

Radiotoxicity of 5-[125I]iodo-2'-deoxyuridine in mammalian cells following treatment with 5-fluoro-2'-deoxyuridine.

Kassis AI, Guptill WE, Taube RA, Adelstein SJ.

J Nucl Biol Med. 1991 Jul-Sep;35(3):167-73.

PMID:
1840093
50.

Antigen-binding site protection during radiolabeling leads to a higher immunoreactive fraction.

Van den Abbeele AD, Aaronson RA, Daher S, Taube RA, Adelstein SJ, Kassis AI.

J Nucl Med. 1991 Jan;32(1):116-22.

Supplemental Content

Support Center